• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE CARDIAC D-DIMER; FIBRINOGEN AND FIBRIN SPLIT PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE CARDIAC D-DIMER; FIBRINOGEN AND FIBRIN SPLIT PRODUCTS Back to Search Results
Catalog Number 04877802190
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/26/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer stated that they received an erroneous result for one patient sample tested for roche cardiac d-dimer (ddi) on a cobas h 232 analyzer.The cobas h 232 analyzer is not sold in the united states, nor is it like or similar to a product sold in the united states.There were no other issues with unexpected results or issues with sample errors.The patient had no known interferences.Two samples were collected from the patient at the same time.One sample was tested on the cobas h 232 analyzer, resulting with a ddi value of 0.33 ug/ml.The second sample was tested using an unknown laboratory method, resulting with a ddi value of 2.31 ug/ml.The results were reported outside of the laboratory to nurses, who advised the patient.The nurses then called about the event.The patient was not adversely affected.The cobas h 232 analyzer serial number was (b)(4).
 
Manufacturer Narrative
A specific root cause could not be determined as the customer material was requested, but not returned.Investigations were performed on retention material from the same lot number.Relevant retention material 14008810 was measured on a cobas h232 analyzers with two native blood samples and two spiked blood samples.Each blood sample was tested three times.The results were as follows: mean of the measurements: first native blood sample: 0.23 ug/ml.Second native blood sample: 0.19 ug/ml.First spiked blood sample (c=0.70 ug/ml): 0.74 ug/ml.Second spiked blood sample (c=2.20 ug/ml): 2.10 ¿u/ml.All measurements performed with this material fulfilled requirements.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE CARDIAC D-DIMER
Type of Device
FIBRINOGEN AND FIBRIN SPLIT PRODUCTS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5939615
MDR Text Key54348243
Report Number1823260-2016-01341
Device Sequence Number1
Product Code DAP
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K033491
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04877802190
Device Lot Number14008810
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/26/2016
Initial Date FDA Received09/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-